Patients with active inflammatory bowel disease (IBD) have increased levels of n3 and decreased levels of n6 plasma long-chain polyunsaturated fatty acids (LC-PUFA). Using multivariate statistical techniques, this study assessed the influence of the potentially important factors of diagnosis (ulcera
N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease
β Scribed by Kan Uchiyama; Makoto Nakamura; Shunichi Odahara; Shigeo Koido; Kiyohiko Katahira; Hiromi Shiraishi; Toshifumi Ohkusa; Kiyotaka Fujise; Hisao Tajiri
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 396 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective
## Background: Psychosocial factors play an important role in the course of inflammatory bowel disease (ibd). however, a simple, valid psychosocial screening instrument that is suitable for short patient-physician contacts does not exist. therefore, the luebeck semistructured interview for psychoso
## Abstract The evidence for beneficial effects of very long chain (VLC) nβ3 polyunsaturated fatty acids (PUFA) on cardiovascular disease (CVD) is strong because it is based on the results of adequately powered intervention trials with disease endpoints. This contrasts with the evidence for a detri